title: An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis.
authors.forename: Espen
authors.initials: E
authors.lastname: Melum
authors.forename: Tom H
authors.initials: TH
authors.lastname: Karlsen
authors.forename: Annika
authors.initials: A
authors.lastname: Bergquist
authors.forename: Erik
authors.initials: E
authors.lastname: Schrumpf
authors.forename: Kirsten M
authors.initials: KM
authors.lastname: Boberg
mesh_terms: D001650:Bile Duct Neoplasms / Q000097:blood / Q000235:genetics*; D001653:Bile Ducts, Intrahepatic; D015415:Biomarkers / Q000097:blood; D016009:Chi-Square Distribution; D018281:Cholangiocarcinoma / Q000097:blood / Q000235:genetics*; D015209:Cholangitis, Sclerosing / Q000097:blood / Q000235:genetics*; D005838:Genotype; D006801:Humans; D015850:Interleukin-6 / Q000097:blood / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D015850:Interleukin-6